179 WPPh (Hydrochlorothiazide and methyldopa 15 mg / 250 mg)
Pill imprint 179 WPPh has been identified as Hydrochlorothiazide and methyldopa 15 mg / 250 mg.
Hydrochlorothiazide/methyldopa is used in the treatment of high blood pressure and belongs to the drug class antiadrenergic agents (central) with thiazides. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/methyldopa 15 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about hydrochlorothiazide/methyldopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antiadrenergic agents (central) with thiazides
- Hydrochlorothiazide and methyldopa
- Methyldopa and hydrochlorothiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.